Avalo Therapeutics, Inc. 4 filing

Filed 2026-05-26 · Report date 2026-05-21 · 2026

View Original SEC Filing

Filing metadata

Accession number: 0001810417-26-000014
Form type: 4
CIK: 0001534120
Primary document: https://www.sec.gov/Archives/edgar/data/1534120/000181041726000014/xslF345X06/form4-05262026_040507.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Avalo Therapeutics, Inc..

Reported financial metrics

Metric	Current	Prior	Change